Missing Links? Citation Matrix Graphs Glossary  HistCite Guide  About
Mon Oct 25 16:32:57 2004

Papers in WoS with "thalidomide" in the title, 1959-2004
and the following papers added from the outer references

MELLIN GW, 1962, NEW ENGL J MED, V267, P1184
MELLIN GW, 1962, NEW ENGL J MED, V267, P1238
LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555
LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232
KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426
SHESKIN J, 1965, LEPROSY REV, V36, P183
WIEDEMANN HR, 1961, MED WELT, V37, P1863
BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095

Nodes: 2685, Authors: 6203, Journals: 662, Outer References: 16023, Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by GCS.
Page 1:  1  2  3  4  5  6  7  8  9
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
114291160 1994 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91(9):4082-4085
DAMATO RJ; LOUGHNAN MS; FLYNN E; FOLKMAN J
THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS
326719
210371588 1999 NEW ENGLAND JOURNAL OF MEDICINE 341(21):1565-1571
Singhal S; Mehta J; Desikan R; Ayers D; Roberson P; Eddlemon P; Munshi N; Anaissie E; Wilson C; Dhodapkar M; Zeldis J; Barlogie B; Siegel D; Crowley J
Antitumor activity of thalidomide in refractory multiple myeloma.
284548
33251045 1991 JOURNAL OF EXPERIMENTAL MEDICINE 173(3):699-703
SAMPAIO EP; SARNO EN; GALILLY R; COHN ZA; KAPLAN G
THALIDOMIDE SELECTIVELY INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY STIMULATED HUMAN MONOCYTES
287498
40045 1961 LANCET 2(721):1358-&
MCBRIDE WG
THALIDOMIDE AND CONGENITAL ABNORMALITIES
181432
51191100 1993 JOURNAL OF EXPERIMENTAL MEDICINE 177(6):1675-1680
MOREIRA AL; SAMPAIO EP; ZMUIDZINAS A; FRINDT P; SMITH KA; KAPLAN G
THALIDOMIDE EXERTS ITS INHIBITORY-ACTION ON TUMOR-NECROSIS-FACTOR-ALPHA BY ENHANCING MESSENGER-RNA DEGRADATION
231424
600330 1965 CLINICAL PHARMACOLOGY & THERAPEUTICS 6(3):303-&
SHESKIN J
THALIDOMIDE IN TREATMENT OF LEPRA REACTIONS
215259
700110 1962 LANCET 1(7219):45-&
LENZ W
THALIDOMIDE AND CONGENITAL ABNORMALITIES
122254
89211070 1992 NEW ENGLAND JOURNAL OF MEDICINE 326(16):1055-1058
VOGELSANG GB; FARMER ER; HESS AD; ALTAMONTE V; BESCHORNER WE; JABS DA; CORIO RL; LEVIN LS; COLVIN OM; WINGARD JR; SANTOS GW
THALIDOMIDE FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE
166253
91231101 1993 JOURNAL OF INFECTIOUS DISEASES 168(2):408-414
SAMPAIO EP; KAPLAN G; MIRANDA A; NERY JAC; MIGUEL CP; VIANA SM; SARNO EN
THE INFLUENCE OF THALIDOMIDE ON THE CLINICAL AND IMMUNOLOGICAL MANIFESTATION OF ERYTHEMA-NODOSUM LEPROSUM
140210
1024441380 1997 NEW ENGLAND JOURNAL OF MEDICINE 336(21):1487-1493
Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
119191
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
111241112 1993 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90(13):5974-5978
MAKONKAWKEYOON S; LIMSONPOBRE RNR; MOREIRA AL; SCHAUF V; KAPLAN G
THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
105184
1223371444 1998 JOURNAL OF EXPERIMENTAL MEDICINE 187(11):1885-1892
Haslett PAJ; Corral LG; Albert M; Kaplan G
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
142177
1310311632 2000 BLOOD 96(9):2943-2950
Hideshima T; Chauhan D; Shima Y; Raje N; Davies FE; Tai YT; Treon SP; Lin B; Schlossman RL; Richardson P; Muller G; Stirling DI; Anderson KC
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
89172
140 168 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(23):1184-1192
MELLIN GW; KATZENSTEIN M
THE SAGA OF THALIDOMIDE. NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES
83169
1513126 1962 LANCET 1(7235):912-&
SOMERS GF
THALIDOMIDE AND CONGENITAL ABNORMALITIES
79168
1623411336 1997 EXPERIMENTAL EYE RESEARCH 64(6):971-978
Kenyon BM; Browne F; DAmato RJ
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
96149
176341739 2000 JOURNAL OF CLINICAL ONCOLOGY 18(4):708-715
Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WKA
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
75147
180041 1961 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 86(52):2555-&
LENZ W
KINDLICHE MISSBILDUNGEN NACH MEDIKAMENT-EINNAHME WAHREND DER GRAVIDITAT
60144
1951597 1962 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 87(24):1232-&
LENZ W; KNAPP K
DIE THALIDOMID-EMBRYOPATHIE
48144
2015341183 1995 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 99(2):160-167
MCHUGH SM; RIFKIN IR; DEIGHTON J; WILSON AB; LACHMANN PJ; LOCKWOOD CM; EWAN PW
THE IMMUNOSUPPRESSIVE DRUG THALIDOMIDE INDUCES T-HELPER CELL-TYPE 2 (TH2) AND CONCOMITANTLY INHIBITS TH1 CYTOKINE PRODUCTION IN MITOGEN-STIMULATED AND ANTIGEN-STIMULATED HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURES
106143
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2121331543 1999 GASTROENTEROLOGY 117(6):1271-1277
Ehrenpreis ED; Kane SV; Cohen LB; Cohen RD; Hanauer SB
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
44131
224181214 1995 MOLECULAR MEDICINE 1(4):384-397
TRAMONTANA JM; UTAIPAT U; MOLLOY A; AKARASEWI P; BURROUGHS M; MAKONKAWKEYOON S; JOHNSON B; KLAUSNER JD; ROM W; KAPLAN G
THALIDOMIDE TREATMENT REDUCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND ENHANCES WEIGHT-GAIN IN PATIENTS WITH PULMONARY TUBERCULOSIS
60130
231134464 1968 JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 31(6):543-&
FULLERTON PM; OSULLIVA.DJ
THALIDOMIDE NEUROPATHY - A CLINICAL ELECTROPHYSIOLOGICAL AND HISTOLOGICAL FOLLOW-UP STUDY
86129
2419401544 1999 GASTROENTEROLOGY 117(6):1278-1287
Vasiliauskas EA; Kam LY; Abreu-Martin MT; Hassard PV; Papadakis KA; Yang HY; Zeldis JB; Targan SR
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
43129
25618102 1962 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 180(13):1106-&
TAUSSIG HB
A STUDY OF GERMAN OUTBREAK OF PHOCOMELIA - THALIDOMIDE SYNDROME
37127
2613381681 2000 BRITISH JOURNAL OF CANCER 82(4):812-817
Eisen T; Boshoff C; Mak I; Sapunar F; Vaughan MM; Pyle L; Johnston SRD; Ahern R; Smith IE; Gore ME
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer
76127
2713251396 1998 ANNALS OF INTERNAL MEDICINE 128(6):443-+
Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial
67126
286331276 1996 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 11(3):247-257
Klausner JD; Makonkawkeyoon S; Akarasewi P; Nakata K; Kasinrerk W; Corral L; Dewar RL; Lane HC; Freedman VH; Kaplan G
The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M-tuberculosis infection
51125
2929116101 1962 EXPERIENTIA 18(9):389-&
FAIGLE JW; SCHMID K; RIESS W; KEBERLE H
METABOLIC FATE OF THALIDOMIDE
73124
3010481563 1999 JOURNAL OF IMMUNOLOGY 163(1):380-386
Corral LG; Haslett PAJ; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
77122
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
3113271406 1998 BIOCHEMICAL PHARMACOLOGY 55(11):1827-1834
Bauer KS; Dixon SC; Figg WD
Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
80120
328191684 2000 BRITISH JOURNAL OF HAEMATOLOGY 109(1):89-96
Juliusson G; Celsing F; Turesson I; Lenhoff S; Adriansson M; Malm C
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
88117
33861011282 1996 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 35(6):969-979
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
76114
3411301357 1997 JOURNAL OF IMMUNOLOGY 159(10):5157-5161
Moller DR; Wysocka M; Greenlee BM; Ma XJ; Wahl L; Flockhart DA; Trinchieri G; Karp CL
Inhibition of IL-12 production by thalidomide
77114
352654784 1982 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 7(3):317-323
BARNHILL RL; MCDOUGALL AC
THALIDOMIDE - USE AND POSSIBLE MODE OF ACTION IN REACTIONAL LEPROMATOUS LEPROSY AND IN VARIOUS OTHER CONDITIONS
84111
369211830 2001 BLOOD 98(2):492-494
Barlogie B; Desikan R; Eddlemon P; Spencer T; Zeldis J; Munshi N; Badros A; Zangari M; Anaissie E; Epstein J; Shaughnessy J; Ayers D; Spoon D; Tricot G
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
66111
3713251585 1999 NATURE MEDICINE 5(5):582-585
Parman T; Wiley MJ; Wells PG
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
65110
383465169 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(24):1238-1244
MELLIN GW; KATZENSTEIN M
THE SAGA OF THALIDOMIDE. NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES
64109
3958804 1983 BRITISH JOURNAL OF DERMATOLOGY 108(4):461-466
KNOP J; BONSMANN G; HAPPLE R; LUDOLPH A; MATZ DR; MIFSUD EJ; MACHER E
THALIDOMIDE IN THE TREATMENT OF 60 CASES OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS
78109
4045992 1989 BRITISH MEDICAL JOURNAL 298(6671):432-432
YOULE M; CLARBOUR J; FARTHING C; CONNOLLY M; HAWKINS D; STAUGHTON R; GAZZARD B
TREATMENT OF RESISTANT APHTHOUS ULCERATION WITH THALIDOMIDE IN PATIENTS POSITIVE FOR HIV ANTIBODY
56103
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
4121261004 1990 ARCHIVES OF DERMATOLOGY 126(7):923-927
REVUZ J; GUILLAUME JC; JANIER M; HANS P; MARCHAND C; SOUTEYRAND P; BONNETBLANC JM; CLAUDY A; DALLAC S; KLENE C; CRICKX B; SANCHOGARNIER H; CHAUMEIL JC
CROSSOVER STUDY OF THALIDOMIDE VS PLACEBO IN SEVERE RECURRENT APHTHOUS STOMATITIS
53100
4271961613 2000 AMERICAN JOURNAL OF MEDICINE 108(6):487-495
Calabrese L; Fleischer AB
Thalidomide: Current and potential clinical applications
5899
4317316 1965 BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 25(2):324-&
SCHUMACHER H; SMITH RL; WILLIAMS RT
METABOLISM OF THALIDOMIDE - SPONTANEOUS HYDROLYSIS OF THALIDOMIDE IN SOLUTION
8998
446381226 1996 AIDS 10(13):1501-1507
ReyesTeran G; SierraMadero JG; delCerro VM; ArroyoFigueroa H; Pasquetti A; Calva JJ; RuizPalacios GM
Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placebo-controlled clinical trial
4997
4519231118 1994 ARCHIVES OF DERMATOLOGY 130(1):66-69
OCHONISKY S; VERROUST J; BASTUJIGARIN S; GHERARDI R; REVUZ J
THALIDOMIDE NEUROPATHY INCIDENCE AND CLINICOELECTROPHYSIOLOGIC FINDINGS IN 42 PATIENTS
7295
469181829 2001 BLOOD 98(1):210-216
Davies FE; Raje N; Hideshima T; Lentzsch S; Young G; Tai YT; Lin B; Podar K; Gupta D; Chauhan D; Treon SP; Richardson PG; Schlossman RL; Morgan GJ; Muller GW; Stirling DI; Anderson KC
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
4891
47351832 2001 BLOOD 98(5):1614-1615
Zangari M; Anaissie E; Barlogie B; Badros A; Desikan R; Gopal AV; Morris C; Toor A; Siegel E; Fink L; Tricot G
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
5990
481024762 1981 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78(4):2545-2548
GORDON GB; SPIELBERG SP; BLAKE DA; BALASUBRAMANIAN V
THALIDOMIDE TERATOGENESIS - EVIDENCE FOR A TOXIC ARENE OXIDE METABOLITE
4889
499281267 1996 IMMUNOPHARMACOLOGY 31(2-3):213-221
Geitz H; Handt S; Zwingenberger K
Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
7089
503920 1961 BRITISH MEDICAL JOURNAL 2(525):855-&
FULLERTON PM; KREMER M
NEUROPATHY AFTER INTAKE OF THALIDOMIDE (DISTAVAL)
6187
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
518171589 1999 NEW ENGLAND JOURNAL OF MEDICINE 341(21):1606-1609
Raje N; Anderson K
Thalidomide - A revival story.
4887
520949 1961 Med Welt 37:1863-1866
WIEDEMANN HR
Indications of a current increase of hypoplastic and aplastic deformities of the extremities
3786
5342443 1961 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 134(1):60-&
KUHN WL; VANMAANEN EF
CENTRAL NERVOUS SYSTEM EFFECTS OF THALIDOMIDE
885
541730878 1985 BRITISH JOURNAL OF DERMATOLOGY 112(4):475-480
WULFF CH; HOYER H; ASBOEHANSEN G; BRODTHAGEN H
DEVELOPMENT OF POLYNEUROPATHY DURING THALIDOMIDE THERAPY
6685
556251175 1995 BLOOD 86(9):3604-3609
PARKER PM; CHAO N; NADEMANEE A; ODONNELL MR; SCHMIDT GM; SNYDER DS; STEIN AS; SMITH EP; MOLINA A; STEPAN DE; KASHYAP A; PLANAS I; SPIELBERGER R; SOMLO G; MARGOLIN K; ZWINGENBERGER K; WILSMAN K; NEGRIN RS; LONG GD; NILAND JC; BLUME KG; FORMAN SJ
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
5185
5610281759 2000 MAYO CLINIC PROCEEDINGS 75(9):897-901
Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
Thalidomide in the treatment of relapsed multiple myeloma
5685
5717441205 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 32(5):866-869
CARLESIMO M; GIUSTINI S; ROSSI A; BONACCORSI P; CALVIERI S
TREATMENT OF CUTANEOUS AND PULMONARY SARCOIDOSIS WITH THALIDOMIDE
4884
5813671740 2000 JOURNAL OF CLINICAL ONCOLOGY 18(13):2593-2602
Little RF; Wyvill KM; Pluda JM; Welles L; Marshall V; Figg WD; Newcomb FM; Tosato G; Feigal E; Steinberg SM; Whitby D; Goedert JJ; Yarchoan R
Activity of thalidomide in AIDS-related Kaposis's sarcoma
4482
591824993 1989 DRUG METABOLISM AND DISPOSITION 17(4):402-405
CHEN TL; VOGELSANG GB; PETTY BG; BRUNDRETT RB; NOE DA; SANTOS GW; COLVIN OM
PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THALIDOMIDE AFTER ORAL DOSING IN HEALTHY MALE-VOLUNTEERS
7781
6019251181 1995 CHIRALITY 7(1):44-52
ERIKSSON T; BJORKMAN S; ROTH B; FYGE A; HOGLUND P
STEREOSPECIFIC DETERMINATION, CHIRAL INVERSION IN-VITRO AND PHARMACOKINETICS IN HUMANS OF THE ENANTIOMERS OF THALIDOMIDE
5679
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
6100690 1979 ARCHIVES OF DERMATOLOGY 115(5):636-637
MASCARO JM; LECHA M; TORRAS H
THALIDOMIDE IN THE TREATMENT OF RECURRENT, NECROTIC, AND GIANT MUCOCUTANEOUS APHTHAE AND APHTHOSIS
6478
628281462 1998 LANCET 352(9140):1586-1589
Wolkenstein P; Latarjet J; Roujeau JC; Duguet C; Boudeau S; Vaillant L; Maignan M; Schuhmacher MH; Milpied B; Pilorget A; Bocquet H; Brun-Buisson C; Revuz J
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
3978
630131 1956 ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 6(8):426-430
KUNZ W; KELLER H; MUCKTER H
N-PHTHALYL-GLUTAMINIC IMIDE
4076
6456117 1962 LANCET 1(7224):303-&
SPEIRS AL
THALIDOMIDE AND CONGENITAL ABNORMALITIES
3376
65001056 1992 DRUG SAFETY 7(2):116-134
GUNZLER V
THALIDOMIDE IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PATIENTS - A REVIEW OF SAFETY CONSIDERATIONS
5975
66171683 2000 BRITISH JOURNAL OF HAEMATOLOGY 108(2):391-393
Kneller A; Raanani P; Hardan I; Avigdor A; Levi I; Berkowicz M; Ben-Bassat I
Therapy with thalidomide in refractory multiple myeloma patients - the revival of an old drug
5375
67512320 1965 BRITISH MEDICAL JOURNAL 2(5463):687-&
HELLMANN K; DUKE DI; TUCKER DF
PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE
4973
68413317 1965 BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 25(2):338-&
SCHUMACHER H; SMITH RL; WILLIAMS RT
METABOLISM OF THALIDOMIDE - FATE OF THALIDOMIDE AND SOME OF ITS HYDROLYSIS PRODUCTS IN VARIOUS SPECIES
5972
69314518 1971 BULLETIN OF THE WORLD HEALTH ORGANIZATION 45(6):719-&
IYER CGS; LANGUILL.J; UEMURA K; TARABINI.G; SUNDARES.T; BECHELLI LM; DOMINGUE.VM; DELASAGU.JT; RAMANUJA.K
WHO COORDINATED SHORT-TERM DOUBLE-BLIND TRIAL WITH THALIDOMIDE IN TREATMENT OF ACUTE LEPRA REACTIONS IN MALE LEPROMATOUS PATIENTS
6272
701527997 1989 JOURNAL OF RHEUMATOLOGY 16(2):158-163
GUTIERREZRODRIGUEZ O; STARUSTABACAL P; GUTIERREZMONTES O
TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS - THE THALIDOMIDE EXPERIENCE
5572
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
7114201037 1991 BRITISH JOURNAL OF HAEMATOLOGY 78(1):23-27
HENEY D; NORFOLK DR; WHEELDON J; BAILEY CC; LEWIS IJ; BARNARD DL
THALIDOMIDE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
5972
7212221116 1994 ANNALS OF THE RHEUMATIC DISEASES 53(12):828-832
GARDNERMEDWIN JMM; SMITH NJ; POWELL RJ
CLINICAL-EXPERIENCE WITH THALIDOMIDE IN THE MANAGEMENT OF SEVERE ORAL AND GENITAL ULCERATION IN CONDITIONS SUCH AS BEHCETS-DISEASE - USE OF NEUROPHYSIOLOGICAL STUDIES TO DETECT THALIDOMIDE NEUROPATHY
5372
731196 1960 BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 15(1):111-116
SOMERS GF
PHARMACOLOGICAL PROPERTIES OF THALIDOMIDE (ALPHA-PHTHALIMIDO GLUTARIMIDE) - NEW SEDATIVE HYPNOTIC DRUG
5271
74820935 1986 TRANSPLANTATION 41(5):644-647
VOGELSANG GB; HESS AD; GORDON G; SANTOS GW
TREATMENT AND PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH THALIDOMIDE IN A RAT MODEL
4771
757191139 1994 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 36(4):351-356
STROMLAND K; NORDIN V; MILLER M; AKERSTROM B; GILLBERG C
AUTISM IN THALIDOMIDE EMBRYOPATHY - A POPULATION STUDY
371
7628980 1988 TERATOLOGY 38(3):203-215
LENZ W
A SHORT HISTORY OF THALIDOMIDE EMBRYOPATHY
3869
7722134 1962 LANCET 2(7249):249-&
KNAPP V; CHRISTIE GA; SELLER MJ
THALIDOMIDE AND CONGENITAL ABNORMALITIES
4268
78313226 1963 LANCET 1(727):249-&
ROATH S; ELVES MW; ISRAELS MCG
EFFECTS OF THALIDOMIDE AND ITS DERIVATIVES ON HUMAN LEUCOCYTES CULTURED IN VITRO
4766
7918719 1980 ARCHIVES OF DERMATOLOGICAL RESEARCH 269(3):275-280
FAURE M; THIVOLET J; GAUCHERAND M
INHIBITION OF PMN LEUKOCYTES CHEMOTAXIS BY THALIDOMIDE
5666
8027901 1985 LEPROSY REVIEW 56(1):35-39
GAD SM; SHANNON EJ; KROTOSKI WA; HASTINGS RC
THALIDOMIDE INDUCES IMBALANCES IN LYMPHOCYTE-T SUB-POPULATIONS IN THE CIRCULATING BLOOD OF HEALTHY-MALES
5065
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
81113484 1962 BRITISH MEDICAL JOURNAL 2(5296):14-&
LECK IM; MILLAR ELM
INCIDENCE OF MALFORMATIONS SINCE INTRODUCTION OF THALIDOMIDE
2564
8221331095 1993 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 11(5):487-493
ATRA E; SATO EI
TREATMENT OF THE CUTANEOUS LESIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE
4664
833161983 1988 TERATOLOGY 38(3):229-239
STEPHENS TD
PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY
4063
8410271152 1994 LIFE SCIENCES 55(2):77-92
NOGUEIRA AC; NEUBERT R; HELGE H; NEUBERT D
THALIDOMIDE AND THE IMMUNE-SYSTEM .3. SIMULTANEOUS UP-REGULATION AND DOWN-REGULATION OF DIFFERENT INTEGRIN RECEPTORS ON HUMAN WHITE BLOOD-CELLS
5663
8561453 1962 ARCHIVES OF ENVIRONMENTAL HEALTH 5(2):100-&
LENZ W; KNAPP K
THALIDOMIDE EMBRYOPATHY
1062
8623137 1962 LANCET 2(7250):298-&
GLICK EN; GIROUD A; TUCHMANNDUPLESSIS H; MERCIERPAROT L
THALIDOMIDE AND CONGENITAL ABNORMALITIES
062
873661853 1984 INTERNATIONAL JOURNAL OF DERMATOLOGY 23(9):598-602
GROSSHANS E; ILLY G
THALIDOMIDE THERAPY FOR INFLAMMATORY DERMATOSES
5562
888211286 1996 MOLECULAR MEDICINE 2(4):506-515
Corral LG; Muller GW; Moreira AL; Chen YX; Wu MD; Stirling D; Kaplan G
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity
4362
89813303 1964 SCIENCE 146(364):1300-&
DELAHUNT CS; LASSEN LJ
THALIDOMIDE SYNDROME IN MONKEYS
2560
9027381186 1995 CLINICAL INFECTIOUS DISEASES 20(2):250-254
PATERSON DL; GEORGHIOU PR; ALLWORTH AM; KEMP RJ
THALIDOMIDE AS TREATMENT OF REFRACTORY APHTHOUS ULCERATION RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
3860
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
9112591831 2001 BLOOD 98(4):958-965
Raza A; Meyer P; Dutt D; Zorat F; Lisak L; Nascimben F; du Randt M; Kaspar C; Goldberg C; Loew J; Dar S; Gezer S; Venugopal P; Zeldis J
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes
2860
92020807 1983 BRITISH MEDICAL JOURNAL 286(6360):199-202
VENNING GR
IDENTIFICATION OF ADVERSE REACTIONS TO NEW DRUGS .1. WHAT HAVE BEEN THE IMPORTANT ADVERSE REACTIONS SINCE THALIDOMIDE
059
93620842 1984 ARCHIVES OF DERMATOLOGY 120(3):338-341
CLEMMENSEN OJ; OLSEN PZ; ANDERSEN KE
THALIDOMIDE NEUROTOXICITY
4159
9426442 1967 NATURE 215(5098):296-&
FABRO S; SMITH RL; WILLIAMS RT
TOXICITY AND TERATOGENICITY OF OPTICAL ISOMERS OF THALIDOMIDE
3058
9524775 1982 ARCHIVES OF DERMATOLOGY 118(8):536-536
SAYLAN T; SALTIK I
THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME
4258
968171906 2001 CLINICAL CANCER RESEARCH 7(7):1888-1893
Figg WD; Dahut W; Duray P; Hamilton M; Tompkins A; Steinberg SM; Jones E; Premkumar A; Linehan WM; Floeter MK; Chen CC; Dixon S; Kohler DR; Kruger EA; Gubish E; Pluda JM; Reed E
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer
2358
97767727 1980 INTERNATIONAL JOURNAL OF DERMATOLOGY 19(6):318-322
SHESKIN J
THE TREATMENT OF LEPRA REACTION IN LEPROMATOUS LEPROSY - 15 YEARS EXPERIENCE WITH THALIDOMIDE
4557
98519912 1986 ARCHIVES OF INTERNAL MEDICINE 146(5):878-881
JORIZZO JL; SCHMALSTIEG FC; SOLOMON AR; CAVALLO T; TAYLOR RS; RUDLOFF HB; SCHMALSTIEG EJ; DANIELS JC
THALIDOMIDE EFFECTS IN BEHCETS-SYNDROME AND PUSTULAR VASCULITIS
2557
997251304 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(12):1047-1054
Haslett P; Hempstead M; Seidman C; Diakun J; Vasquez D; Freedman VH; Kaplan G
The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus
3657
10013271437 1998 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 236(6):461-466
Kruse FE; Joussen AM; Rohrschneider K; Becker MD; Volcker HE
Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor
3957
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
101341985 2001 NEW ENGLAND JOURNAL OF MEDICINE 344(25):1951-1952
Osman K; Comenzo R; Rajkumar SV
Deep venous thrombosis and thalidomide therapy for multiple myeloma.
4457
10210361254 1996 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 81(3):219-223
Klausner JD; Freedman VH; Kaplan G
Thalidomide as an anti-TNF-alpha inhibitor: Implications for clinical use
3956
1032255717 1980 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 107(6):515-523
SAMSOEN M; GROSSHANS E; BASSET A
THALIDOMIDE IN THE TREATMENT OF DISCOID LUPUS-ERYTHEMATOSUS (DLE)
4755
1041224844 1984 ARTHRITIS AND RHEUMATISM 27(10):1118-1121
GUTIERREZRODRIGUEZ O
THALIDOMIDE - A PROMISING NEW TREATMENT FOR RHEUMATOID-ARTHRITIS
4655
1057222476 2003 JOURNAL OF CLINICAL ONCOLOGY 21(1):16-19
Weber D; Rankin K; Gavino M; Delasalle K; Alexanian R
Thalidomide alone or with dexamethasone for previously untreated multiple myeloma
2955
106721467 1968 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 160(1):201-&
SCHUMACHER H; BLAKE DA; GILLETTE JR
DISPOSITION OF THALIDOMIDE IN RABBITS AND RATS
4454
1071339745 1981 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 31-1(6):941-949
HELM FC; FRANKUS E; FRIDERICHS E; GRAUDUMS I; FLOHE L
COMPARATIVE TERATOLOGICAL INVESTIGATION OF COMPOUNDS STRUCTURALLY AND PHARMACOLOGICALLY RELATED TO THALIDOMIDE
054
10810551473 1998 PAIN 74(1):83-91
Sommer C; Marziniak M; Myers RR
The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve
554
10928531955 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(25):22382-22387
Keifer JA; Guttridge DC; Ashburner BP; Baldwin AS
Inhibition of NF-kappa B activity by thalidomide through suppression of I kappa B kinase activity
3154
1108131159 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):901-904
POWELL RJ; GARDNERMEDWIN JMM
GUIDELINE FOR THE CLINICAL USE AND DISPENSING OF THALIDOMIDE
3953
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
111381490 1999 ARTHRITIS AND RHEUMATISM 42(3):580-581
Breban M; Gombert B; Amor B; Dougados M
Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis
1653
11222981690 2000 CANCER TREATMENT REVIEWS 26(5):351-362
Rajkumar SV; Witzig TE
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma
2953
11327401741 2000 JOURNAL OF CLINICAL ONCOLOGY 18(14):2710-2717
Baidas SM; Winer EP; Fleming GF; Harris L; Pluda JM; Crawford JG; Yamauchi H; Isaacs C; Hanfelt J; Tefft M; Flockhart D; Johnson MD; Hawkins MJ; Lippman ME; Hayes DF
Phase II evaluation of thalidomide in patients with metastatic breast cancer
3853
11412352057 2002 BLOOD 99(12):4525-4530
Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Richardson PG; Hideshima T; Munshi NC; Treon SP; Anderson KC
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
1353
1150 344 1965 LEPROSY REVIEW 36:183-187
SHESKIN J
Further observations with thalidomide in lepra reactions
3852
1168341264 1996 HEPATOLOGY 23(6):1616-1621
LopezTalavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Thalidomide inhibits tumor necrosis factor alpha decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats
752
117251367 1997 LANCET 350(9089):1445-1446
Wettstein AR; Meagher AP
Thalidomide in Crohn's disease
3452
11822372226 2002 JOURNAL OF CLINICAL ONCOLOGY 20(21):4319-4323
Rajkumar SV; Hayman S; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR; Geyer S; Iturria N; Fonseca R; Lust JA; Kyle RA; Witzig TE
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
2952
119007 1960 BRITISH MEDICAL JOURNAL 2(DEC31):1954-1954
FLORENCE AL
IS THALIDOMIDE TO BLAME
4351
12010181235 1996 ANTI-CANCER DRUGS 7(3):339-343
Minchinton AI; Fryer KH; Wendt KR; Clow KA; Hayes MMM
The effect of thalidomide on experimental tumors and metastases
2950
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
121312576 1973 LANCET 2(7837):1058-1061
MCCREDIE J
THALIDOMIDE AND CONGENITAL CHARCOTS JOINTS
849
12250891087 1993 ARCHIVES OF TOXICOLOGY 67(1):1-17
NEUBERT R; NOGUEIRA AC; NEUBERT D
THALIDOMIDE DERIVATIVES AND THE IMMUNE-SYSTEM .1. CHANGES IN THE PATTERN OF INTEGRIN RECEPTORS AND OTHER SURFACE-MARKERS ON LYMPHOCYTE-T SUBPOPULATIONS OF MARMOSET BLOOD
4049
12319231319 1997 BRITISH JOURNAL OF RHEUMATOLOGY 36(3):353-359
Stevens RJ; Andujar C; Edwards CJ; Ames PRJ; Barwick AR; Khamashta MA; Hughes GRV
Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: Experience in sixteen consecutive patients
3649
12414301445 1998 JOURNAL OF IMMUNOLOGY 161(8):4236-4243
Marriott JB; Westby M; Cookson S; Guckian M; Goodbourn S; Muller G; Shire MG; Stirling D; Dalgleish AG
CC-3052: A water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production
3349
12500154 1962 LANCET 2(7265):1116-&
KING CTG; KENDRICK FJ
TERATOGENIC EFFECTS OF THALIDOMIDE IN SPRAGUE DAWLEY RAT
2248
126212404 1966 NATURE 211(5055):1308-&
FIELD EO; GIBBS JE; TUCKER DF; HELLMANN K
EFFECT OF THALIDOMIDE ON GRAFT VERSUS HOST REACTION
4148
127710720 1980 ARCHIVES OF DERMATOLOGY 116(5):571-572
VANDENBROEK H
TREATMENT OF PRURIGO NODULARIS WITH THALIDOMIDE
3548
1282239855 1984 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 11(5):814-819
BARNHILL RL; DOLL NJ; MILLIKAN LE; HASTINGS RC
STUDIES ON THE ANTI-INFLAMMATORY PROPERTIES OF THALIDOMIDE - EFFECTS ON POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES
4248
12917261279 1996 JOURNAL OF MEDICINAL CHEMISTRY 39(17):3238-3240
Muller GW; Corral LG; Shire MG; Wang H; Moreira A; Kaplan G; Stirling DI
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity
3348
13021331439 1998 IMMUNOPHARMACOLOGY 40(1):11-20
Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I
Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells
3648
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
13100115 1962 LANCET 1(7223):271-&
LENZ W
THALIDOMIDE AND CONGENITAL ABNORMALITIES - REPLY
2247
132618128 1962 LANCET 1(7242):1270-&
SMITHELLS RW
THALIDOMIDE AND MALFORMATIONS IN LIVERPOOL
2447
13301145 1962 LANCET 2(7258):724-&
FELISATI D; KNAPP VI
THALIDOMIDE AND CONGENITAL ABNORMALITIES
2847
1340 189 1963 ARZNEIMITTEL-FORSCHUNG 13:185-191
BECKMANN R
The behavior of thalidomide in the human and animal organism. part 2.
3547
13513321293 1996 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 93(15):7552-7556
Turk BE; Jiang H; Liu JO
Binding of thalidomide to alpha(1)-acid glyeoprotein may be involved in its inhibition of tumor necrosis factor alpha production
3947
13612431303 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(10):857-863
Moreira AL; Corral LG; Ye WG; Johnson B; Stirling D; Muller GW; Freedman VH; Kaplan G
Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro
3647
13719281570 1999 JOURNAL OF PHARMACEUTICAL SCIENCES 88(1):121-125
Figg WD; Raje S; Bauer KS; Tompkins A; Venzon D; Bergan R; Chen A; Hamilton M; Pluda J; Reed E
Pharmacokinetics of thalidomide in an elderly prostate cancer population
3347
1386281390 1997 TUBERCLE AND LUNG DISEASE 78(1):47-55
Moreira AL; Tsenova-Berkova L; Wang J; Laochumroonvorapong P; Freeman S; Freedman VH; Kaplan G
Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis
2146
1391633466 1968 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 160(1):189-&
SCHUMACHER H; BLAKE DA; GURIAN JM; GILLETTE JR
A COMPARISON OF TERATOGENIC ACTIVITY OF THALIDOMIDE IN RABBITS AND RATS
2345
1406171532 1999 CLINICAL THERAPEUTICS 21(2):319-330
Zeldis JB; Williams BA; Thomas SD; Elsayed ME
STEPS (TM): A comprehensive program for controlling and monitoring access to thalidomide
3745
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
14143521549 1999 IMMUNOLOGY TODAY 20(12):538-540
Marriott JB; Muller G; Dalgleish AG
Thalidomide as an emerging immunotherapeutic agent
3645
14213111 1962 LANCET 1(7219):45-&
PFEIFFER RA; KOSENOW W
THALIDOMIDE AND CONGENITAL ABNORMALITIES - REPLY
2544
14338779 1982 BRITISH JOURNAL OF DERMATOLOGY 107(1):83-86
NAAFS B; BAKKERS EJM; FLINTERMAN J; FABER WR
THALIDOMIDE TREATMENT OF SUB-ACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS
3044
14413171051 1991 TRANSPLANTATION 52(5):908-910
KEENAN RJ; EIRAS G; BURCKART GJ; STUART RS; HARDESTY RL; VOGELSANG G; GRIFFITH BP; ZEEVI A
IMMUNOSUPPRESSIVE PROPERTIES OF THALIDOMIDE - INHIBITION OF INVITRO LYMPHOCYTE-PROLIFERATION ALONE AND IN COMBINATION WITH CYCLOSPORINE OR FK506
3944
1456281442 1998 INTERNATIONAL JOURNAL OF STD & AIDS 9(12):751-755
Fife K; Howard MR; Gracie F; Phillips RH; Bower M
Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre
2844
146312261 1963 SCIENCE 139(355):110-&
FRANK O; LEEVY CM; HUTNER SH; BAKER H; ZIFFER H; AARONSON S
METABOLIC DEFICIENCIES IN PROTOZOA INDUCED BY THALIDOMIDE
2543
147691060 1992 JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS 582(1-2):211-216
ERIKSSON T; BJORKMAN S; FYGE A; EKBERG H
DETERMINATION OF THALIDOMIDE IN PLASMA AND BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - AVOIDING HYDROLYTIC DEGRADATION
4343
1486111120 1994 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 199(2):455-460
NISHIMURA K; HASHIMOTO Y; IWASAKI S
ENHANCEMENT OF PHORBOL ESTER-INDUCED PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY THALIDOMIDE
2643
1493231155 1994 NEPHRON 67(3):270-273
SILVA SRB; VIANA PCF; LUGON NV; HOETTE M; RUZANY F; LUGON JR
THALIDOMIDE FOR THE TREATMENT OF UREMIC PRURITUS - A CROSSOVER RANDOMIZED DOUBLE-BLIND TRIAL
2043
15010191975 2001 LEUKEMIA 15(8):1274-1276
Rajkumar SV; Dispenzieri A; Fonseca R; Lacy MQ; Geyer S; Lust JA; Kyle RA; Greipp PR; Gertz MA; Witzig TE
Thalidomide for previously untreated indolent or smoldering multiple myeloma
2843
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
151520890 1985 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 53(2):201-205
MONCADA B; BARANDA ML; GONZALEZAMARO R; URBINA R; LOREDO CE
THALIDOMIDE - EFFECT ON T-CELL SUBSETS AS A POSSIBLE MECHANISM OF ACTION
3142
1521018892 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 12(1):85-90
GRINSPAN D
SIGNIFICANT RESPONSE OF ORAL APHTHOSIS TO THALIDOMIDE TREATMENT
2542
15311391338 1997 GASTROENTEROLOGY 112(6):1823-1829
Sharpstone D; Rowbottom A; Francis N; Tovey G; Ellis D; Barrett M; Gazzard B
Thalidomide: A novel therapy for microsporidiosis
1242
154610220 1963 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 183(2):139-&
DIPAOLO JA
CONGENITAL MALFORMATION IN STRAIN A MICE - ITS EXPERIMENTAL PRODUCTION BY THALIDOMIDE
041
155019729 1980 JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME 62(3):307-320
HAMANISHI C
CONGENITAL SHORT FEMUR - CLINICAL, GENETIC AND EPIDEMIOLOGICAL COMPARISON OF THE NATURALLY-OCCURRING CONDITION WITH THAT CAUSED BY THALIDOMIDE
041
156436765 1981 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 13(6):553-562
SHANNON EJ; MIRANDA RO; MORALES MJ; HASTINGS RC
INHIBITION OF DENOVO IGM ANTIBODY-SYNTHESIS BY THALIDOMIDE AS A RELEVANT MECHANISM OF ACTION IN LEPROSY
3241
157721805 1983 BRITISH JOURNAL OF DERMATOLOGY 108(4):467-471
LOVELL CR; HAWK JLM; CALNAN CD; MAGNUS IA
THALIDOMIDE IN ACTINIC PRURIGO
2141
1585251178 1995 BRITISH JOURNAL OF CANCER 72(2):339-343
CHING LM; XU ZF; GUMMER BH; PALMER BD; JOSEPH WR; BAGULEY BC
EFFECT OF THALIDOMIDE ON TUMOR-NECROSIS-FACTOR PRODUCTION AND ANTITUMOR-ACTIVITY INDUCED BY 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID
2541
159422335 1965 HUMANGENETIK 1(6):516-536
NOWACK E
CORRELATION BETWEEN THE PERIOD OF THALIDOMIDE-ADMINISTRATION AND EMBRYOPATHY
1940
16003441 1967 NATURE 214(5092):1018-&
LUTWAKMA.C; SCHMID K; KEBERLE H
THALIDOMIDE IN RABBIT SEMEN
040
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
161822501 1970 CLINICAL PHARMACOLOGY & THERAPEUTICS 11(4):481-&
HASTINGS RC; TRAUTMAN JR; ENNA CD; JACOBSON RR
THALIDOMIDE IN TREATMENT OF ERYTHEMA NODOSUM LEPROSUM - WITH A NOTE ON SELECTED LABORATORY ABNORMALITIES IN ERYTHEMA NODOSUM LEPROSUM
3040
16229411084 1993 ARCHIVES OF DERMATOLOGY 129(10):1261-1264
THOMAS L; DUCROS B; SECCHI T; BALME B; MOULIN G
SUCCESSFUL TREATMENT OF ADULTS LANGERHANS CELL HISTIOCYTOSIS WITH THALIDOMIDE - REPORT OF 2 CASES AND LITERATURE-REVIEW
2340
16349951701 2000 CURRENT OPINION IN ONCOLOGY 12(6):564-573
Thomas DA; Kantarjian HM
Current role of thalidomide in cancer treatment
1640
164541201707 2000 DRUGS 60(2):273-292
Peuckmann V; Fisch M; Bruera E
Potential novel uses of thalidomide - Focus on palliative care
2740
1655131811 2001 ANNALS OF ONCOLOGY 12(7):991-995
Dimopoulos MA; Zervas K; Kouvatseas G; Galani E; Grigoraki V; Kiamouris C; Vervessou E; Samantas E; Papadimitriou C; Economou O; Gika D; Panayiotidis P; Christakis I; Anagnostopoulos N
Thalidomide and dexamethasone combination for refractory multiple myeloma
2940
16601232 1963 LANCET 1(728):723-&
WILLIAMS RT
TERATOGENIC EFFECTS OF THALIDOMIDE AND RELATED SUBSTANCES
1839
1671237285 1964 JOURNAL OF PEDIATRICS 64(5):762-&
BRENT RL
DRUG TESTING IN ANIMALS FOR TERATOGENIC EFFECTS - THALIDOMIDE IN PREGNANT RAT
539
16800917 1986 CLINICAL RHEUMATOLOGY 5(3):365-371
HAMZA MH
TREATMENT OF BEHCETS-DISEASE WITH THALIDOMIDE
2139
169461103 1993 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 28(2):271-272
GHIGLIOTTI G; REPETTO T; FARRIS A; ROY MT; DEMARCHI R
THALIDOMIDE - TREATMENT OF CHOICE FOR APHTHOUS ULCERS IN PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS
3139
1700595 1962 COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES 156(5):765-&
GIROUD A; MERCIERPAROT L; TUCHMANNDUPLESS.H
OBSERVATIONS SUR LES REPERCUSSIONS TERATOGENES DE LA THALIDOMIDE CHEZ LA SOURIS ET LE LAPIN
1438
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1711735843 1984 ARCHIVES OF DERMATOLOGY 120(11):1466-1470
ARONSON IK; YU R; WEST DP; VANDENBROEK H; ANTEL J
THALIDOMIDE-INDUCED PERIPHERAL NEUROPATHY - EFFECT OF SERUM FACTOR ON NERVE CULTURES
3438
1721119963 1988 BONE MARROW TRANSPLANTATION 3(5):393-398
VOGELSANG GB; HESS AD; SANTOS GW
THALIDOMIDE FOR TREATMENT OF GRAFT-VERSUS-HOST DISEASE
3138
17311271069 1992 LIFE SCIENCES 51(26):2107-2116
NEUBERT R; NOGUEIRA AC; NEUBERT D
THALIDOMIDE AND THE IMMUNE-SYSTEM .2. CHANGES IN RECEPTORS ON BLOOD-CELLS OF A HEALTHY VOLUNTEER
3238
174832151277 1996 JOURNAL OF INFLAMMATION 46(4):177-211
Zwingenberger K; Wnendt S
Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations
3338
1755321384 1997 RESPIRATORY MEDICINE 91(1):31-39
Tavares JL; Wangoo A; Dilworth P; Marshall B; Kotecha S; Shaw RJ
Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages
2338
1766171564 1999 JOURNAL OF INFECTIOUS DISEASES 180(1):61-67
Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N; Natl Inst Allergy Infect Dis AIDS Clin Trials G
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection
2738
17700127 1962 LANCET 1(7239):1128-&
PLIESS G
THALIDOMIDE AND CONGENITAL ABNORMALITIES
2237
17837262 1963 SCIENCE 139(356):1295-&
LUCEY JF; BEHRMAN RE
THALIDOMIDE - EFFECT UPON PROGNANCY IN RHESUS MONKEY
1737
17914651 1977 LANCET 1(8005):251-251
ERAVELLY J; WATERS MFR
THALIDOMIDE IN WEBER-CHRISTIAN DISEASE
3237
18010251199 1995 IMMUNOPHARMACOLOGY 31(1):109-116
SHANNON EJ; SANDOVAL F
THALIDOMIDE INCREASES THE SYNTHESIS OF IL-2 IN CULTURES OF HUMAN MONONUCLEAR-CELLS STIMULATED WITH CONCANAVALIN-A, STAPHYLOCOCCAL-ENTEROTOXIN-A, AND PURIFIED PROTEIN DERIVATIVE
3437
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1815141234 1996 ANNALS OF THE RHEUMATIC DISEASES 55(11):833-836
Huizinga TWJ; Dijkmans BAC; vanderVelde EA; Kraan TCTMV; Verweij CL; Breedveld FC
An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis
2037
1827271936 2001 HAEMATOLOGICA 86(4):399-403
Palumbo A; Giaccone L; Bertola A; Pregno P; Bringhen S; Rus C; Triolo S; Gallo E; Pileri A; Boccadoro M
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma
2437
18310402005 2001 SEMINARS IN ONCOLOGY 28(4):62-66
Figg WD; Arlen P; Gulley J; Fernandez P; Noone M; Fedenko K; Hamilton M; Parker C; Kruger EA; Pluda J; Dahut WL
A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer
1537
18417149 1962 LANCET 2(7260):836-&
KEMPER FH
THALIDOMIDE AND CONGENITAL ABNORMALITIES
2536
18502275 1964 BRITISH MEDICAL JOURNAL 1(539):1090-&
LUTWAKMANN C
OBSERVATIONS ON PROGENY OF THALIDOMIDE-TREATED MALE RABBITS
836
18614692 1979 BRITISH MEDICAL JOURNAL 1(6166):792-792
WATERS MFR; LAING ABG; AMBIKAPATHY A; LENNARDJONES JE
TREATMENT OF ULCERATIVE-COLITIS WITH THALIDOMIDE
2736
18700773 1982 ANNALES DE PEDIATRIE 29(1):67-69
VENENCIE PY; SAURAT JH
PYODERMA GANGRENOSUM IN A CHILD - TREATMENT WITH THALIDOMIDE
2036
1881624886 1985 INTERNATIONAL JOURNAL OF DERMATOLOGY 24(2):131-134
NAAFS B; FABER WR
THALIDOMIDE THERAPY - AN OPEN TRIAL
2736
18922219984 1988 TERATOLOGY 38(3):241-251
BRENT RL; HOLMES LB
CLINICAL AND BASIC SCIENCE LESSONS FROM THE THALIDOMIDE TRAGEDY - WHAT HAVE WE LEARNED ABOUT THE CAUSES OF LIMB DEFECTS
636
190001188 1995 DRUG SAFETY 12(6):364-369
SCHULER U; EHNINGER G
THALIDOMIDE - RATIONALE FOR RENEWED USE IN IMMUNOLOGICAL DISORDERS
2536
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
19114231417 1998 BONE MARROW TRANSPLANTATION 21(6):577-581
Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasiulli A; Vassallo E; Miniero R; Uderzo C
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
2636
19226801430 1998 CURRENT MEDICINAL CHEMISTRY 5(3):163-178
Hashimoto Y
Novel biological response modifiers derived from thalidomide
1436
19310281567 1999 JOURNAL OF NEURO-ONCOLOGY 43(2):109-114
Moreira AL; Friedlander DR; Shif B; Kaplan G; Zagzag D
Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro
2236
194361741629 2000 BIOCHEMICAL PHARMACOLOGY 59(12):1489-1499
Stephens TD; Bunde CJW; Fillmore BJ
Mechanism of action in thalidomide teratogenesis
2436
1952267167 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(23):1179-&
MAHON WA; MITCHELL ML; KATZENSTEIN M; STEINKE J; RABEN MS
SAGA OF THALIDOMIDE - NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES
035
196425187 1963 AMERICAN JOURNAL OF PATHOLOGY 43(6):999-&
MARINPADILLA M; BENIRSCHKE K
THALIDOMIDE INDUCED ALTERATIONS IN BLASTOCYST AND PLACENTA OF ARMADILLO, DASYPUS NOVEMCINCTUS MEXICANUS, INCLUDING A CHORIOCARCINOMA
635
197711859 1984 LANCET 2(8417):1424-1426
JENKINS JS; POWELL RJ; ALLEN BR; LITTLEWOOD SM; MAURICE PDL; SMITH NJ
THALIDOMIDE IN SEVERE OROGENITAL ULCERATION
2535
19844970 1988 LANCET 1(8577):117-117
LIM SH; MCWHANNELL A; VORA AJ; BOUGHTON BJ
SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
3235
1995211937 2001 HAEMATOLOGICA 86(4):404-408
Hus M; Dmoszynska A; Soroka-Wojtaszko M; Jawniak D; Legiec W; Ciepnuch H; Hellmann A; Wolska-Smolen T; Skotnicki A; Manko J; Polish Multiple Myeloma Study Grp
Thalidomide treatment of resistant or relapsed multiple myeloma patients
2335
20037290 1964 LIFE SCIENCES 3(9):987-992
FABRO S; SCHUMACHER H; SMITH RL; WILLIAMS RT
TERATOGENIC ACTIVITY OF THALIDOMIDE AND RELATED COMPOUNDS
2034
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2011341356 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(2):268-&
FRATTA ID; SIGG EB; MAIORANA K
TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS RATS HAMSTERS AND MICE
1534
202315934 1986 TOXICOLOGY AND APPLIED PHARMACOLOGY 82(1):175-179
BRAUN AG; HARDING FA; WEINREB SL
TERATOGEN METABOLISM - THALIDOMIDE ACTIVATION IS MEDIATED BY CYTOCHROME-P-450
2734
2037141017 1990 JOURNAL OF INTERNAL MEDICINE 228(4):405-407
LARSSON H
TREATMENT OF SEVERE COLITIS IN BEHCETS-SYNDROME WITH THALIDOMIDE (CG-217)
1934
204141047 1991 LANCET 337(8738):436-437
WILLIAMS I; WELLER IVD; MALIN A; ANDERSON J; WATERS MFR
THALIDOMIDE HYPERSENSITIVITY IN AIDS
2634
20526331140 1994 EUROPEAN JOURNAL OF DERMATOLOGY 4(1):9-15
OCHONISKY S; REVUZ J
THALIDOMIDE USE IN DERMATOLOGY
2934
206151166 1995 AIDS 9(6):658-659
SHARPSTONE D; ROWBOTTOM A; NELSON M; GAZZARD B
THE TREATMENT OF MICROSPORIDIAL DIARRHEA WITH THALIDOMIDE
1434
207701122034 2002 ANNUAL REVIEW OF MEDICINE 53:629-657
Richardson P; Hideshima T; Anderson K
Thalidomide: Emerging role in cancer medicine
2134
2086202219 2002 JOURNAL OF CLINICAL ONCOLOGY 20(1):302-306
Motzer RJ; Berg W; Ginsberg M; Russo P; Vuky J; Yu R; Bacik J; Mazumdar M
Phase II trial of thalidomide for patients with advanced renal cell carcinoma
2034
20922230 1963 LANCET 1(728):552-&
BOYLEN JB; JOHNSON WJ; HORNE HH
TERATOGENIC EFFECTS OF THALIDOMIDE AND RELATED SUBSTANCES
2033
210739384 1966 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 16:289-&
JURAND A
EARLY CHANGES IN LIMB BUDS OF CHICK EMBRYOS AFTER THALIDOMIDE TREATMENT
733
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
211228635 1977 ACTA NEUROPATHOLOGICA 39(3):271-280
SCHRODER JM; GIBBELS E
UNMYELINATED NERVE-FIBERS IN SENILE NERVES AND IN LATE THALIDOMIDE NEUROPATHY - QUANTITATIVE ELECTRON-MICROSCOPIC STUDY
1033
212691071 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(3):208-209
RYAN J; COLMAN J; PEDERSEN J; BENSON E
THALIDOMIDE TO TREAT ESOPHAGEAL ULCER IN AIDS
2433
21315221253 1996 CHIRALITY 8(5):390-396
Wnendt S; Finkam M; Winter W; Ossig J; Raabe G; Zwingenberger K
Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues
2733
21412391482 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(13):1169-1179
Haslett PAJ; Klausner JD; Makonkawkeyoon S; Moreira A; Metatratip P; Boyle B; Kunachiwa W; Maneekarn N; Vongchan P; Corral LG; Elbeik T; Shen Z; Kaplan G
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients
2733
2159241615 2000 AMERICAN JOURNAL OF PATHOLOGY 156(1):151-158
Sauer H; Gunther J; Hescheler J; Wartenberg M
Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals
1633
216461769 2000 NEW ENGLAND JOURNAL OF MEDICINE 343(13):972-973
Rajkumar SV; Gertz MA; Witzig TE
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma.
2333
217310395 1966 LANCET 1(7447):1134-&
TURK JL; HELLMANN K; DUKE DI
EFFECT OF THALIDOMIDE ON IMMUNOLOGICAL RESPONSE IN LOCAL LYMPH NODES AFTER A SKIN HOMOGRAFT
2832
218512560 1972 TERATOLOGY 5(2):233-&
SCHUMACHER HJ; WILSON JG; TERAPANE J; JORDAN RR
TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOG, EM12, IN RABBITS, RATS, AND MONKEYS
1432
21938661 1977 TERATOLOGY 16(3):333-335
SCOTT WJ; FRADKIN R; WILSON JG
NON-CONFIRMATION OF THALIDOMIDE INDUCED TERATOGENESIS IN RATS AND MICE
1832
2201825800 1983 ARCHIVES OF DERMATOLOGY 119(10):812-815
HASPER MF
CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS - THALIDOMIDE TREATMENT OF 11 PATIENTS
2132
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
22126953 1987 TRANSPLANTATION PROCEEDINGS 19(1):2658-2661
VOGELSANG GB; HESS AD; GORDON G; BRUNDRETTE R; SANTOS GW
THALIDOMIDE INDUCTION OF BONE-MARROW TRANSPLANTATION TOLERANCE
2432
2223151202 1995 JOURNAL OF INFECTIOUS DISEASES 172(4):1137-1140
PETERSON PK; HU SX; SHENG WS; KRAVITZ FH; MOLITOR TW; CHATTERJEE D; CHAO CC
THALIDOMIDE INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED AND LIPOARABINOMANNAN-STIMULATED HUMAN MICROGLIAL CELLS
2032
2238161302 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(4):301-304
Alexander LN; Wilcox CM
A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers
2532
22431501325 1997 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 110(2):151-154
McHugh SM; Rowland TL
Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation
1732
225261679 2000 BONE MARROW TRANSPLANTATION 25(12):1319-1320
Zomas A; Anagnostopoulos N; Dimopoulos MA
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
1832
22668871924 2001 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 57(5):365-376
Eriksson T; Bjorkman S; Hoglund P
Clinical pharmacology of thalidomide
2232
22700131 1962 LANCET 2(7246):100-&
SPENCER KEV
THALIDOMIDE AND CONGENITAL ABNORMALITIES
1831
228721318 1965 BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 25(2):352-&
FABRO S; SCHUMACHER H; SMITH RL; STAGG RBL; WILLIAMS RT
METABOLISM OF THALIDOMIDE-SOME BIOLOGICAL EFFECTS OF THALIDOMIDE AND ITS METABOLITES
2631
229211722 1980 CHEMISCHE BERICHTE-RECUEIL 113(6):2318-2322
BLASCHKE G; KRAFT HP; MARKGRAF H
CHROMATOGRAPHIC RESOLUTIONS OF RACEMATES .10. OPTICAL RESOLUTION OF THALIDOMIDE AND OTHER GLUTARIMIDE DERIVATIVES
731
23035971 1988 LANCET 1(8581):359-359
SAURAT JH; CAMENZIND M; HELG C; CHAPUIS B
THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
2631
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
231331021 1990 LANCET 335(8701):1343-1343
GORIN I; VILETTE B; GEHANNO P; ESCANDE JP
THALIDOMIDE IN HYPERALGIC PHARYNGEAL ULCERATION OF AIDS
2131
232571065 1992 LANCET 339(8792):549-550
BESSIS D; GUILLOT B; MONPOINT S; DANDURAND M; GUILHOU JJ
THALIDOMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
2731
233191145 1994 JOURNAL OF CHROMATOGRAPHY A 666(1-2):235-240
KNOCHE B; BLASCHKE G
INVESTIGATIONS ON THE IN-VITRO RACEMIZATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
2031
2345131255 1996 CLINICAL INFECTIOUS DISEASES 23(3):501-503
Soler RA; Howard M; Brink NS; Gibb D; Tedder RS; Nadal D
Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide
2431
235231081370 1997 MEDICAL HYPOTHESES 49(2):123-131
McCarty MF
Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: Potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis
1731
2364131409 1998 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 8(19):2669-2674
Muller GW; Shire MG; Wong LM; Corral LG; Patterson RT; Chen YX; Stirling DI
Thalidomide analogs and PDE4 inhibition
2031
23711331452 1998 JOURNAL OF RHEUMATOLOGY 25(5):964-969
Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
The effect of thalidomide and 2 analogs on collagen induced arthritis
1531
2387421521 1999 BRITISH JOURNAL OF CANCER 79(1):114-118
Verheul HMW; Panigrahy D; Yuan J; D'Amato RJ
Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
1631
2397111584 1999 NATURE MEDICINE 5(5):489-490
Hales BF
Thalidomide on the comeback trail
2931
24014411738 2000 JOURNAL OF CHROMATOGRAPHY A 876(1-2):157-167
Meyring M; Chankvetadze B; Blaschke G
Simultaneous separation and enantioseparation of thalidomide and its hydroxylated metabolites using high-performance liquid chromatography in common-size columns, capillary liquid chromatography and nonaqueous capillary electrochromatography
331
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2416482004 2001 SEMINARS IN HEMATOLOGY 38(3):250-259
Barlogie B; Zangari M; Spencer T; Fassas A; Anaissie E; Badros A; Cromer J; Tricot G
Thalidomide in the management of multiple myeloma
1831
2424232058 2002 BLOOD 100(4):1168-1171
Zangari M; Siegel E; Barlogie B; Anaissie E; Saghafifar F; Fassas A; Morris C; Fink L; Tricot G
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy
1731
24317146 1962 LANCET 2(7260):812-&
ROATH S; ISRAELS MCG; ELVES MW
EFFECT OF THALIDOMIDE ON LEUCOCYTE CULTURES
2230
244319286 1964 JOURNAL OF REPRODUCTION AND FERTILITY 8(1):59-&
HAY MF
EFFECTS OF THALIDOMIDE ON PREGNANCY IN RABBIT
930
24546347 1965 NATURE 208(5016):1208-&
FABRO S; SMITH RL; WILLIAMS RT
THALIDOMIDE AS A POSSIBLE BIOLOGICAL ACYLATING AGENT
1830
24612353 1965 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 58(7):493-&
LIVINGST.G
CONGENITAL EAR ABNORMALITIES DUE TO THALIDOMIDE
030
24700613 1975 HAUTARZT 26(4):215-215
SHESKIN J
THERAPY OF PRURIGO NODULARIS HYDE WITH THALIDOMIDE
2830
2481228923 1986 JOURNAL OF NEUROLOGY 233(2):83-89
HESS CW; HUNZIKER T; KUPFER A; LUDIN HP
THALIDOMIDE-INDUCED PERIPHERAL NEUROPATHY - A PROSPECTIVE CLINICAL, NEUROPHYSIOLOGICAL AND PHARMACOGENETIC EVALUATION
2630
2493131019 1990 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 23(3):523-525
RADEFF B; KUFFER R; SAMSON J
RECURRENT APHTHOUS ULCER IN PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - SUCCESSFUL TREATMENT WITH THALIDOMIDE
1830
25027421124 1994 BONE MARROW TRANSPLANTATION 14(6):937-942
COLE CH; ROGERS PCJ; PRITCHARD S; PHILLIPS G; CHAN KW
THALIDOMIDE IN THE MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION
2530
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
25113251328 1997 CLINICAL INFECTIOUS DISEASES 24(6):1223-1227
Haslett P; Tramontana J; Burroughs M; Hempstead M; Kaplan G
Adverse reactions to thalidomide in patients infected with human immunodeficiency virus
2230
2526121486 1999 ANNALS OF ONCOLOGY 10(7):857-859
Bruera E; Neumann CM; Pituskin E; Calder K; Ball G; Hanson J
Thalidomide in patients with cachexia due to terminal cancer: Preliminary report
1430
25311411793 2000 TERATOLOGY 61(3):189-195
Stephens TD; Fillmore BJ
Hypothesis: Thalidomide embryopathy - Proposed mechanism of action
1730
25416371883 2001 BRITISH JOURNAL OF CANCER 85(7):953-958
Stebbing J; Benson C; Eisen T; Pyle L; Smalley K; Bridle H; Mak I; Sapunar F; Ahern R; Gore ME
The treatment of advanced renal cell cancer with high-dose oral thalidomide
1830
25516175 1962 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 109(3):511-&
MACKENZIE RD; MCGRATH WR
ABSORPTION OF THALIDOMIDE IN RAT
2529
256966465 1968 JOURNAL OF PHARMACEUTICAL SCIENCES 57(5):757-&
SHEALY YF; OPLIGER CE; MONTGOME.JA
SYNTHESIS OF D-AND L-THALIDOMIDE AND RELATED STUDIES
1229
257437525 1971 JOURNAL OF THE CHEMICAL SOCIETY B-PHYSICAL ORGANIC (6):1073-&
ALLEN FH; TROTTER J
CRYSTAL AND MOLECULAR STRUCTURE OF THALIDOMIDE, N-(ALPHA-GLUTARIMIDO)-PHTHALIMIDE
529
2581424658 1977 TERATOLOGY 16(1):79-82
MCBRIDE WG
THALIDOMIDE EMBRYOPATHY
1129
25911181455 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39(5):835-838
Lee JB; Koblenzer PS
Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: A case report
1429
2603121893 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(3):605-608
Neben K; Moehler T; Kraemer A; Benner A; Egerer G; Ho AD; Goldschmidt H
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion
1929
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
26113351907 2001 CLINICAL CANCER RESEARCH 7(9):2675-2681
Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho AD; Goldschmidt H
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
1529
26212561909 2001 CLINICAL CANCER RESEARCH 7(11):3349-3355
Fujita J; Mestre JR; Zeldis JB; Subbaramaiah K; Dannenberg AJ
Thalidomide and its analogues inhibit lipopolysaccharide-mediated induction of cyclooxygenase-2
1929
263213604 1974 TERATOLOGY 10(3):283-291
MCBRIDE WG
FETAL NERVE-CELL DEGENERATION PRODUCED BY THALIDOMIDE IN RABBITS
1128
264620633 1976 TERATOLOGY 14(1):71-87
MCBRIDE WG
STUDIES OF ETIOLOGY OF THALIDOMIDE DYSMORPHOGENESIS
628
2651941929 1986 MUSCLE & NERVE 9(9):837-844
LAGUENY A; ROMMEL A; VIGNOLLY B; TAIEB A; VENDEAUDBUSQUET M; DOUTRE MS; JULIEN J
THALIDOMIDE NEUROPATHY - AN ELECTROPHYSIOLOGIC STUDY
2128
26627982 1988 TERATOLOGY 38(3):221-226
KELSEY FO
THALIDOMIDE UPDATE - REGULATORY ASPECTS
1628
26713231424 1998 CHIRALITY 10(3):223-228
Eriksson T; Bjorkman S; Roth B; Fyge A; Hoglund P
Enantiomers of thalidomide: Blood distribution and the influence of serum albumin on chiral inversion and hydrolysis
1728
26844531489 1999 ARCHIVES OF DERMATOLOGY 135(9):1079-1087
Duong DJ; Spigel GT; Moxley RT; Gaspari AA
American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus
1928
26920271751 2000 JOURNAL OF RHEUMATOLOGY 27(6):1429-1433
Ordi-Ros J; Cortes F; Cucurull E; Mauri M; Bujan S; Vilardell M
Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy
1528
27015352199 2002 HAEMATOLOGICA 87(4):408-414
Tosi P; Zamagni E; Cellini C; Ronconi S; Patriarca F; Ballerini F; Musto P; Di Raimondo F; Ledda A; Lauria F; Masini L; Gobbi M; Vacca A; Ria R; Cangini D; Tura S; Baccarani M; Cavo M
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
1928
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
27123422231 2002 JOURNAL OF IMMUNOLOGY 168(10):4914-4919
Dredge K; Marriott JB; Todryk SM; Muller GW; Chen R; Stirling DI; Dalgleish AG
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
1328
272617329 1965 CLINICAL PHARMACOLOGY & THERAPEUTICS 6(3):298-&
GRABSTAL.H; GOLBEY R
CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER
027
2731151542 1972 ACTA PHARMACEUTICA SUECICA 9(6):543-562
JONSSON NA
CHEMICAL STRUCTURE AND TERATOGENIC PROPERTIES .4. OUTLINE OF A CHEMICAL HYPOTHESIS FOR TERATOGENIC ACTION OF THALIDOMIDE
1527
27411563 1973 BRITISH MEDICAL JOURNAL 1(5848):269-272
SMITHELL.RW
DEFECTS AND DISABILITIES OF THALIDOMIDE CHILDREN
027
275813839 1984 ACTA DERMATO-VENEREOLOGICA 64(5):412-417
WINKELMANN RK; CONNOLLY SM; DOYLE JA; PADILHAGONCALVES A
THALIDOMIDE TREATMENT OF PRURIGO NODULARIS
1727
2761338909 1985 TERATOLOGY 32(1):133-144
NEWMAN CGH
TERATOGEN UPDATE - CLINICAL ASPECTS OF THALIDOMIDE EMBRYOPATHY - A CONTINUING PREOCCUPATION
827
27717936 1986 TRANSPLANTATION PROCEEDINGS 18(4):904-906
VOGELSANG GB; TAYLOR S; GORDON G; HESS AD
THALIDOMIDE, A POTENT AGENT FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1927
2783131020 1990 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 23(5):941-944
RUSTIN MHA; GILKES JJH; ROBINSON TWE
PYODERMA-GANGRENOSUM ASSOCIATED WITH BEHCETS-DISEASE - TREATMENT WITH THALIDOMIDE
1427
279001518 1999 BLOOD 94(10):604A-604A
Weber DM; Gavino M; Delasalle K; Rankin K; Giralt S; Alexanian R
Thalidomide alone or with dexamethasone for multiple myeloma.
027
28020401603 1999 SURGERY 125(5):536-544
Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N
Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
1227
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
28117321609 2000 AIDS RESEARCH AND HUMAN RETROVIRUSES 16(14):1345-1355
Kaplan G; Thomas S; Fierer DS; Mulligan K; Haslett PAJ; Fessel WJ; Smith LG; Kook KA; Stirling D; Schambelan M
Thalidomide for the treatment of AIDS-associated wasting
1327
28210201616 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(2):171-174
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Thalidomide and thrombosis.
2527
28318271728 2000 INTERNATIONAL JOURNAL OF DERMATOLOGY 39(5):383-388
Walchner M; Meurer M; Plewig G; Messer G
Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus
1627
28412441743 2000 JOURNAL OF INFECTIOUS DISEASES 181(3):954-965
Bekker LG; Haslett P; Maartens G; Steyn L; Kaplan G
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis
1827
285251753 2000 LANCET 356(9229):566-567
Govindarajan R; Heaton KM; Broadwater R; Zeitlin A; Lang NP; Hauer-Jensen M
Effect of thalidomide on gastrointestinal toxic effects of irinotecan
2027
2867221959 2001 JOURNAL OF CLINICAL ONCOLOGY 19(16):3596-3601
Dimopoulos MA; Zomas A; Viniou NA; Grigoraki V; Galani E; Matsouka C; Economou O; Anagnostopoulos N; Panayiotidis P
Treatment of Waldenstrom's macroglobulinemia with thalidomide
1627
287210271 1964 ARCHIVES OF OTOLARYNGOLOGY 80(2):136-140
DAVIGNON M; BARR B
EAR ABNORMALITIES AND CRANIAL NERVE PALSIES IN THALIDOMIDE CHILDREN
526
288814328 1965 CLINICAL PHARMACOLOGY & THERAPEUTICS 6(3):292-&
OLSON KB; HALL TC; HORTON J; KHUNG CL; HOSLEY HF
THALIDOMIDE (N-PHTHALOYLGLUTAMIMIDE) IN TREATMENT OF ADVANCED CANCER
2226
28947105541 1972 ACTA PHARMACEUTICA SUECICA 9(6):521-542
JONSSON NA
CHEMICAL STRUCTURE AND TERATOGENIC PROPERTIES .3. REVIEW OF AVAILABLE DATA ON STRUCTURE-ACTIVITY RELATIONSHIPS AND MECHANISM OF ACTION OF THALIDOMIDE ANALOGS
1726
290524550 1972 DEVELOPMENTAL BIOLOGY 28(1):61-&
LASH JW; SAXEN L
HUMAN TERATOGENESIS - IN-VITRO STUDIES ON THALIDOMIDE-INHIBITED CHONDROGENESIS
926
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
29120381023 1990 LEUKEMIA RESEARCH 14(5):395-399
WOOD PMD; PROCTOR SJ
THE POTENTIAL USE OF THALIDOMIDE IN THE THERAPY OF GRAFT-VERSUS-HOST DISEASE - A REVIEW OF CLINICAL AND LABORATORY INFORMATION
1726
29211261035 1990 TRANSPLANTATION 49(1):20-25
TAMURA F; VOGELSANG GB; REITZ BA; BAUMGARTNER WA; HERSKOWITZ A
COMBINATION THALIDOMIDE AND CYCLOSPORINE FOR CARDIAC ALLOGRAFT-REJECTION - COMPARISON WITH COMBINATION METHYLPREDNISOLONE AND CYCLOSPORINE
2026
29337611114 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(2):65-76
DARCY PF; GRIFFIN JP
THALIDOMIDE REVISITED
2126
29453741343 1997 INTERNATIONAL JOURNAL OF DERMATOLOGY 36(12):881-887
Calderon P; Anzilotti M; Phelps R
Thalidomide in dermatology. New indications for an old drug
2126
29512211345 1997 INTERNATIONAL JOURNAL OF ONCOLOGY 10(5):965-969
Nguyen M; Tran C; Barsky S; Sun JR; McBride W; Pegram M; Pietras R; Love S; Glaspy J
Thalidomide and chemotherapy combination: Preliminary results of preclinical and clinical studies
2026
2968241420 1998 BRITISH JOURNAL OF CANCER 78(3):336-343
Ching LM; Browne WL; Tchernegovski R; Gregory T; Baguley BC; Palmer BD
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity
1626
2979411446 1998 JOURNAL OF INFECTIOUS DISEASES 177(6):1563-1572
Tsenova L; Sokol K; Freedman VH; Kaplan G
Combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death
1426
298001637 2000 BLOOD 96(11):167A-167A
Weber DM; Rankin K; Gavino M; Delasalle K; Alexanian R
Thalidomide with dexamethasone for resistant multiple myeloma.
026
2990101787 2000 SEMINARS IN HEMATOLOGY 37(1):22-25
Alexanian R; Weber D
Thalidomide for resistant and relapsing myeloma
2226
3006161810 2001 ANNALS OF ONCOLOGY 12(7):987-990
Bertolini F; Mingrone W; Alietti A; Ferrucci PF; Cocorocchio E; Peccatori F; Cineri S; Mancuso P; Corsini C; Burlini A; Zucca E; Martinelli G
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
1626

Page 1:  1  2  3  4  5  6  7  8  9
Generated by: HistCite(Vlad). Version: 2004.09.22